Pfizer’s mRNA Flu Vaccine Achieves 34.5% Higher Effectiveness in Landmark Phase 3 Trial Against Traditional Shots
Pfizer's mRNA flu vaccine outperforms traditional shots by 34.5% in a major…
Eli Lilly Alzheimer’s Drug Trial Delivers 40% Slowdown in Cognitive Decline: Phase 3 Results Spark FDA Fast-Track Hopes
Eli Lilly's phase 3 trial for new Alzheimer's drug shows 40% slowdown…
